Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 139	$ 110
Adjustments to reconcile net income to net cash used in operating activities
Depreciation and amortization	2,740	2,839
Amortization of deferred financing costs	88	58
Loss on disposal of equipment		36
Stock-based compensation expense	191	1,556
Bad debt expense	229	153
Equity income, net of distributions in 2011 and 2010 of $1,555 and and $3,630, respectively	(1,484)	(2,399)
Gain on sale of equity investment in EyakTek, net of transaction costs in 2011 and 2010 of $640 and $0, respectively	(7,278)
Deferred tax expense (benefit)	101	(2,894)
Changes in operating assets and liabilities, net of acquisition:
Accounts receivable	55,524	12,854
Inventory	3,399	(5,725)
Other assets	4,189	6,753
Accounts payable	2,869	(21,669)
Accrued liabilities	(194)	(1,909)
Other liabilities	(558)	1,097
Net cash provided by (used in) operating activities	59,955	(9,140)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of depreciable assets	(199)	(295)
Sale of equity investment in EyakTek	20,000
Acquisition of InSysCo, net of cash acquired	(12,004)
Net cash provided by (used in) investing activities	7,797	(295)
CASH FLOWS FROM FINANCING ACTIVITES:
(Payments) Borrowings under non-interest bearing floor plan financing, net	(14,881)	19,804
Payments of deferred financing costs	(509)
Proceeds from exercise of Stock Options		123
Proceeds from issuance of stock from ESPP plan	81	160
Shares withheld from minimum tax withholding on vested restricted stock awards	(27)	(113)
Repurchase of common stock	(115)	(894)
Excess tax benefit from stock awards		(253)
Net cash (used in) provided by financing activities	(15,451)	18,827
NET INCREASE IN CASH	52,301	9,392
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	4,049	7,894
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 56,350	$ 17,286